News & Stories

The grand opening of our new 400,000-square-foot manufacturing facility in Johor Bahru, Malaysia represents a heavy investment in our business, including dramatically expanding our production capabilities to ensure customers have uninterrupted access to our life-changing products and technology. The facility is twice the size of our highly automated manufacturing facility in Acton, Massachusetts, helping us strengthen our business resiliency and fuel future global growth. The facility was designed with sustainable elements to eventually achieve both Green Building Index (GBI) certification and Leadership in Energy and Environmental Design (LEED) Silver certification, part of Insulet’s global effort to minimize its environmental impact in the areas where we operate.

Insulet’s Omnipod 5 Automated Insulin Delivery (AID) System is now indicated for people with type 2 diabetes (ages 18 years and older) in the United States, making it the first and only AID system FDA-cleared for both type 1 and type 2 diabetes management. This clearance was supported by the results of Insulet’s landmark SECURE-T2D clinical trial, which showed significant glycemic and quality of life improvements with the use of Omnipod 5 compared with prior methods of insulin delivery.

One of the biggest social media trends among Insulet customers is the posting of Pod change videos. Thanks to a new initiative from our marketing team, the community now has a song created specifically to accompany Pod change content.​ The Pod Drop was created using sounds exclusively from an Omnipod 5 Pod change. From peeling back the wrapper of a new Pod to tapping out the air bubbles in a syringe, Insulet was inspired to highlight these moments with a song that brings some pep to their routine. The result is a snappy, happy song celebrating the freedom that Omnipod brings to diabetes management. Insulet has pledged to donate $1 to Breakthrough T1D for each post that uses the song, up to $5,000.